The abrupt halt of US funding for global AIDS programs has created a crisis, jeopardizing years of progress. UNAIDS warns of potentially 4 million AIDS-related deaths and 6 million new HIV infections by 2029 without funding replacement. The US withdrawal has destabilized supply chains, closed health facilities, and disrupted prevention efforts. While a new injectable drug offers hope, its high price may limit access. Experts emphasize the critical need for data collection, now compromised due to the funding cuts. The situation highlights the uneven progress against HIV, particularly in sub-Saharan Africa, and the urgent need for alternative funding sources.

Prepared by Olivia Bennett and reviewed by editorial team.